Ryan Charles S. (CIK 1624830) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-23). Recent activity: Buy QNCX (7,548 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-23 | Quince Therapeutics, Inc. (QNCX) | President | Buy | 7,548 | $9,058 |
来源：SEC Form 4 申报文件 · 截至 2025-06-23